Table 2.
Recent Drug Delivery System | Advantages | Disadvantages | Therapeutic Use | References |
---|---|---|---|---|
Red Blood Cell Membrane-Camouflaged Nanoparticles Drug Delivery System | Avoids triggering the immune system and achieves long-term circulation. Inherent biocompatibility and biodegradability which avoid accumulation related toxicity. |
Being camouflaged as part of the biological system, complex issues of regulation may arise, also, protein identification, purification, and conjugation may be bypassed. | erythrocyte membrane-coated Nano-formulations have been applied in antitumor and anticancer research to substantial accomplishment | [45,46]. [124] |
Hyaluronic Acid-Based Drug Nano Carriers Drug Delivery Systems | Good biocompatibility, biodegradable and non-immunogenicity, it has the ability to recognize over-expressed cells and kill them | They may increase cell proliferation when they interact with certain protein receptors, potentially hazardous to cancer patients | Cancer chemotherapy | [56,125] |
Hexagonal Boron Nitride Nano sheet Drug Delivery System | Biocompatibility, very little to no level of toxicity, high drug-loading ability | Hydrophobicity makes it challenging to function in a biological system | Used in tumor labeling and sensing | [57] |
Polymer-Lipid Hybrid Nanoparticles Drug Delivery System | Physical stability in encapsulation and biocompatibility, in vivo cell delivery efficacy | Poor drug entrapment and loading capacity, Inflammation and tissue damage can affect or inactivate lipids in serum. | Targeted anticancer therapy | [65,126,127] |
Self-Micro emulsifying Drug-Delivery System | Bioavailability of poor solubility drugs, long duration stability, protection of drug-sensitive materials, availability of the liquid and solid forms of drugs | Interaction of drugs could potentially accelerate physical aging in patients due to interactions of glyceride and oxidation of vegetable oil. | Used in the treatment of pulmonary infections | [128,129] |
In-Situ Gel Drug Delivery System | Increased patient compliance, reduced number of administrations, increased bioavailability, controlled and sustained release | Only drugs with a low dosage can be given, eating and drinking may be restricted after administration for a few hours, low stability due to chemical degradation, require more fluid | Employed in rhinitis, used to reduce ocular intolerance in glaucoma, and insulin permeation interactions. | [83,130] |
Micro Electro Mechanical Systems (Mems) For Drug Delivery | Large drug loading capacity, bioavailability, precise drug delivery, efficient and less painful | Requires repeated surgeries for refilling | Heart-related conditions, contraceptives in women | [105,108,115] |
Combination drug delivery approach | More loading capacity and increased efficacy, sustained drug release, limited cytotoxicity, and immunogenicity. | There could be low patient compliance, inflexible fixed dose ratio, incompatible pharmacokinetics, increased toxicity | Chemotherapy, hypothermia therapy | [117,119,131] |
Targeted Drug Delivery System | Reduced side effects and increased efficacy, materials can be metabolized by the liver and kidney thus lower the level of toxicity | High cost of productivity, immunogenicity, and non-specificity of the targeting ligand, can be easily clearance from the blood | Cancer therapy, tumor-related diseases. | [120,132,133] |